Evidence map›Paper›PMID 30712865›Full record

ArticleCell2019

Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion.

Alexandra C Walls, Xiaoli Xiong, Young-Jun Park, M Alejandra Tortorici, Joost Snijder, Joel Quispe, Elisabetta Cameroni, Robin Gopal, Mian Dai, Antonio Lanzavecchia and 4 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Cell, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 414 papers.

0numbers the graph read from it
0cells of the map it votes in
414citing papers in PubMed
84.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

414 citing papers in PubMed, 689 citations in OpenAlex.

  1. Article
  2. Article
  3. TMPRSS2-mediated coronavirus spike activation and inhibition.Nature structural & molecular biology · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Human coronavirus HKU1 neutralization by glycan receptor mimicry.bioRxiv : the preprint server for biology · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

354 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 4 countries.

Alexandra C WallsDepartment of Biochemistry, University of Washington, Seattle, Washington 98195, USA.
Xiaoli XiongDepartment of Biochemistry, University of Washington, Seattle, Washington 98195, USA.
Young-Jun ParkDepartment of Biochemistry, University of Washington, Seattle, Washington 98195, USA.
M Alejandra TortoriciDepartment of Biochemistry, University of Washington, Seattle, Washington 98195, USA; Institute Pasteur & CNRS UMR 3569, Unité de Virologie Structurale, 75015, Paris, France.
Joost SnijderDepartment of Biochemistry, University of Washington, Seattle, Washington 98195, USA.
Joel QuispeDepartment of Biochemistry, University of Washington, Seattle, Washington 98195, USA.
Elisabetta CameroniHumabs Biomed SA, Vir Biotechnology, 6500 Bellinzona, Switzerland.
Robin GopalNational Infection Service, Public Health England, London NW9 5HT, UK.
Mian DaiCrick Worldwide Influenza Centre, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.
Antonio LanzavecchiaInstitute for Research in Biomedicine, Faculty of Biomedical Sciences, Università della Svizzera italiana, 6500 Bellinzona, Switzerland.
Maria ZambonNational Infection Service, Public Health England, London NW9 5HT, UK.
Félix A ReyInstitute Pasteur & CNRS UMR 3569, Unité de Virologie Structurale, 75015, Paris, France.
Davide CortiHumabs Biomed SA, Vir Biotechnology, 6500 Bellinzona, Switzerland.
David VeeslerDepartment of Biochemistry, University of Washington, Seattle, Washington 98195, USA. Electronic address: dveesler@uw.edu.
University of Washington · USCentre National de la Recherche Scientifique · FRPublic Health England · GBVir Biotechnology (Switzerland) · CHThe Francis Crick Institute · GBUniversità della Svizzera italiana · CH

Funding

TRAINING IN MOLECULAR BIOPHYSICST32GM008268 · NIGMS · UNIVERSITY OF WASHINGTON · PI KOLLMAN, JUSTIN M, ZHENG, NING · 1988 to 2023
$8.6M
Structural Studies of Coronavirus Fusion ProteinsR01GM120553 · NIGMS · UNIVERSITY OF WASHINGTON · PI VEESLER, DAVID · 2016 to 2020
$1.7M
Pilatus 6mS10OD021832 · OD · UNIVERSITY OF CALIFORNIA BERKELEY · PI ADAMS, PAUL DAVID · 2016 to 2016
$980k
NIAID NIH HHS HHSN272201700059CNIGMS NIH HHS R01 GM120553NIGMS NIH HHS T32 GM008268NIH HHS S10 OD021832
6 · The paper itself

Abstract

Recent outbreaks of severe acute respiratory syndrome and Middle East respiratory syndrome, along with the threat of a future coronavirus-mediated pandemic, underscore the importance of finding ways to combat these viruses. The trimeric spike transmembrane glycoprotein S mediates entry into host cells and is the major target of neutralizing antibodies. To understand the humoral immune response elicited upon natural infections with coronaviruses, we structurally characterized the SARS-CoV and MERS-CoV S glycoproteins in complex with neutralizing antibodies isolated from human survivors. Although the two antibodies studied blocked attachment to the host cell receptor, only the anti-SARS-CoV S antibody triggered fusogenic conformational changes via receptor functional mimicry. These results provide a structural framework for understanding coronavirus neutralization by human antibodies and shed light on activation of coronavirus membrane fusion, which takes place through a receptor-driven ratcheting mechanism.

Indexed as

AnimalsAntibodies, MonoclonalAntibodies, NeutralizingAntibodies, ViralChlorocebus aethiopsCoronavirusCoronavirus InfectionsHEK293 CellsHumansImmunity, HumoralMiddle East Respiratory Syndrome CoronavirusMolecular MimicryProtein BindingReceptors, VirusSevere acute respiratory syndrome-related coronavirusSpike Glycoprotein, CoronavirusAntibodies, MonoclonalAntibodies, NeutralizingAntibodies, ViralReceptors, VirusSpike Glycoprotein, Coronavirusclass I fusion proteincoronavirusglycoproteomicsmembrane fusionMERS-CoVneutralizing antibodiesN-linked glycosylationSARS-CoVspike glycoprotein

Identifiers

PMID30712865
PMCPMC6751136
OpenAlexW2915009278

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.